Page last updated: 2024-08-23

raloxifene hydrochloride and Body Weight

raloxifene hydrochloride has been researched along with Body Weight in 37 studies

Research

Studies (37)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.70)18.7374
1990's6 (16.22)18.2507
2000's17 (45.95)29.6817
2010's12 (32.43)24.3611
2020's1 (2.70)2.80

Authors

AuthorsStudies
Chan, CO; Mok, DK; Poon, CC; Wong, KY; Wong, MS; Xiao, H; Yu, W; Zhou, L1
Andrade, TU; Bissoli, NS; Caliman, IF; Dalpiaz, PLM; Firmes, LB; Gouvea, SA; Lamas, AZ; Medeiros, ARS; Nascimento, AM; Oliveira, PWC; Reis, AM; Sousa, GJ1
Blaeser, A; Bollinger, LE; Harper, AD; Lu, P; Lu, QL; Shah, SN; Sparks, S; Wu, B1
Kawasaki, N; Nagai, N; Nakazawa, Y; Ogata, F; Otake, H1
Ilhan, N; Ozercan, IH; Susam, S; Tatar, O1
Fang, M; Huang, W; Wu, XC1
Della Torre, S; Eva, C; Fontana, R; Longo, A; Maggi, AC; Meda, C1
Dullin, C; Hallecker, J; Komrakova, M; Schaefer, N; Sehmisch, S; Stuermer, EK; Stuermer, KM; Tezval, M1
Chaves-Neto, AH; Dornelles, RC; Ervolino, E; Louzada, MJ; Nakamune, AC; Rossi, AC; Santos, LF; Singulani, MP; Stringhetta-Garcia, CT1
Ichimura, R; Inoue, K; Kuwata, K; Morikawa, T; Takahashi, M; Usuda, K; Watanabe, G; Yokosuka, M; Yoshida, M1
Chang, CC; Chang, T; Chuang, CL; Hsin, IF; Hsu, SJ; Huang, HC; Lee, FY; Lee, SD; Lee, WS1
Fujimura, A; Hasegawa, G; Kaneda, T; Maeda, A; Tsuruoka, S1
Baird, JP; Fudge, MA; Kavaliers, M; Ossenkopp, KP1
Hasegawa, Y; Inaji, H; Matsumura, Y; Nakagawa, E; Nishida, M; Ohkita, M; Tanida, I1
Cegieła, U; Folwarczna, J; Kaczmarczyk-Sedlak, I; Nowińska, B; Pytlik, M; Sliwiński, L; Trzeciak, H; Trzeciak, HI1
Altunay, H; Bilgili, H; Gecit, MR; Keskin, D; Tasci, A1
da Silva, BB; dos Santos, AR; Lopes-Costa, PV; Rodrigues-Junior, DM1
Baron, J; Falk, J; Nilsson, O; Ritzén, EM; Sävendahl, L1
Fried, A; Segev, E; Wientroub, S; Zeitlin, L1
Anderson, DW; Bhagwat, SS; Brady, H; Gayo-Fung, LM; Leisten, J; Lipps, SG; McKie, JA; O'Leary, E; Patnaik, N; Stein, B; Sutherland, MK1
Coppola, A; Di Carlo, C; Di Carlo, R; Esposito, E; Meli, R; Nappi, C; Nasti, A; Pacilio, M; Raso, GM1
Bracamonte, MP; Jayachandran, M; LaBreche, P; Miller, VM; Mukherjee, R; Okano, H; Owen, WG; Steinkamp, T1
Leitzbach, D; Linz, W; Madajka, M; Malinski, T; Weckler, N; Wiemer, G1
Armamento-Villareal, R; Brodt, MD; Caruso, PL; Civelli, M; Civitelli, R; Galbiati, E; Halstead, LR; Mueller, C; Napoli, N; Nawaz, A; Sheikh, S; Silva, MJ1
Jayachandran, M; Miller, VM; Okano, H; Yoshikawa, A1
Davis, AM; Ellersieck, MR; Grimm, KM; Rosenfeld, CS1
Cano, A; del Val, R; García-Pérez, MA; Hermenegildo, C; Noguera, I; Noguera, R1
Bryant, HU; Evans, G; Magee, D; Sato, M; Turner, RT1
Bekele, A; Bendele, R; Bensch, WR; Black, LJ; Cullinan, GJ; Kauffman, RF; Magee, DE; Rowley, ER; Sato, M; Williams, DC1
Black, EC; Bryant, HU; Chandrasekhar, S; Frolik, CA; Magee, DE1
Bemis, K; Bryant, HU; Burr, DB; Helterbrand, J; Higgs, R; Iversen, P; Owan, I; Sato, M; Smietana, F; Takano, Y; Turner, CH1
Adrian, MD; Bryant, HU; Rowley, E; Sato, M; Turner, CH; Wang, T1
Butterworth, M; Greaves, P; Green, A; Parrott, E; White, IN1
Adámeková, E; Ahlers, I; Ahlersová, E; Bojková, B; Cermáková, M; Chamilová, M; Kalická, K; Kubatka, P1
Bury, PS; Clarke, CH; Cunningham, KA; de Beun, R; Koldzic-Zivanovic, N; Thomas, ML; Wassermann, K; Zhou, W1
Bern, HA; Chou, YC; Iguchi, T1
Jordan, VC; Lindgren, JU; Phelps, E1

Other Studies

37 other study(ies) available for raloxifene hydrochloride and Body Weight

ArticleYear
Water extract of Er-xian decoction selectively exerts estrogenic activities and interacts with SERMs in estrogen-sensitive tissues.
    Journal of ethnopharmacology, 2021, Jul-15, Volume: 275

    Topics: Alkaline Phosphatase; Animals; Body Weight; Bone and Bones; Breast; Cell Line, Tumor; Central Nervous System; Corpus Striatum; Drugs, Chinese Herbal; Estradiol; Estrogens; Female; Herb-Drug Interactions; Hormones; Humans; Mammary Glands, Human; Medicine, Chinese Traditional; Models, Biological; Ovariectomy; Raloxifene Hydrochloride; Rats, Sprague-Dawley; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Uterus; Water

2021
The selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen improve ANP levels and decrease nuclear translocation of NF-kB in estrogen-deficient rats.
    Pharmacological reports : PR, 2017, Volume: 69, Issue:4

    Topics: Active Transport, Cell Nucleus; Animals; Atrial Natriuretic Factor; Body Weight; Estrogens; Female; Heart; Hemodynamics; Myocardium; NF-kappa B; Organ Size; Ovariectomy; Raloxifene Hydrochloride; Rats; Selective Estrogen Receptor Modulators; Tamoxifen; Uterus

2017
Long-Term Treatment of Tamoxifen and Raloxifene Alleviates Dystrophic Phenotype and Enhances Muscle Functions of FKRP Dystroglycanopathy.
    The American journal of pathology, 2018, Volume: 188, Issue:4

    Topics: Animals; Body Weight; Bone Density; Dystroglycans; Female; Glycosylation; Heart; Male; Mice, Inbred C57BL; Muscles; Muscular Dystrophy, Animal; Organ Specificity; Pentosyltransferases; Phenotype; Proteins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Transferases

2018
Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Administration, Cutaneous; Animals; Biological Availability; Body Weight; Calcium; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Liberation; Endocytosis; Male; Menthol; Nanoparticles; Osteoporosis; Ovariectomy; Particle Size; Raloxifene Hydrochloride; Rats, Wistar; Skin Absorption; Solubility

2018
Is there any potential anticancer effect of raloxifene and fluoxetine on DMBA-induced rat breast cancer?
    Journal of biochemical and molecular toxicology, 2019, Volume: 33, Issue:9

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Body Weight; Carcinogens; Enzyme-Linked Immunosorbent Assay; Female; Fluoxetine; Mammary Neoplasms, Experimental; Raloxifene Hydrochloride; Rats; Rats, Wistar; Weight Gain

2019
Raloxifene upregulated mesangial cell MMP-2 activity via ER-β through transcriptional regulation.
    Cell biochemistry and biophysics, 2013, Volume: 67, Issue:2

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Estrogen Receptor beta; Female; Gene Expression Regulation, Enzymologic; Matrix Metalloproteinase 2; Mesangial Cells; Mice; Protein Kinase Inhibitors; Raloxifene Hydrochloride; Tissue Inhibitor of Metalloproteinase-2; Transcription Factor AP-2; Transcription, Genetic; Up-Regulation

2013
Estrogen replacement therapy regulation of energy metabolism in female mouse hypothalamus.
    Endocrinology, 2014, Volume: 155, Issue:6

    Topics: Animals; Body Weight; Energy Metabolism; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hypothalamus; Indoles; Mice; Raloxifene Hydrochloride

2014
Whole body vibration during fracture healing intensifies the effects of estradiol and raloxifene in estrogen-deficient rats.
    Bone, 2014, Volume: 64

    Topics: Animals; Body Weight; Bone Density Conservation Agents; Estradiol; Estrogens; Feeding Behavior; Female; Fracture Healing; Gene Expression; Organ Size; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Vibration; X-Ray Microtomography

2014
The effects of strength training and raloxifene on bone health in aging ovariectomized rats.
    Bone, 2016, Volume: 85

    Topics: Aging; Animals; Biomarkers; Body Weight; Bone and Bones; Bone Density; Bone Remodeling; Estradiol; Female; Femur; Imaging, Three-Dimensional; Organ Size; Ovariectomy; Raloxifene Hydrochloride; Rats, Wistar; Resistance Training; Uterus

2016
Neonatal exposure to SERMs disrupts neuroendocrine development and postnatal reproductive function through alteration of hypothalamic kisspeptin neurons in female rats.
    Neurotoxicology, 2016, Volume: 56

    Topics: Age Factors; Animals; Animals, Newborn; Body Weight; Developmental Disabilities; Disease Models, Animal; Endocrine System Diseases; Estradiol; Estrous Cycle; Female; Hormones; Hypothalamus; Kisspeptins; Neurons; Ovariectomy; Pregnancy; Progesterone; Raloxifene Hydrochloride; Rats; Selective Estrogen Receptor Modulators; Tamoxifen

2016
Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats.
    European journal of pharmacology, 2017, May-05, Volume: 802

    Topics: Ammonia; Animals; Body Weight; Female; Fibrosis; Gene Expression Regulation; Hemodynamics; Hepatic Encephalopathy; Hypertension, Portal; Liver; Liver Cirrhosis; Motor Activity; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; RNA, Messenger

2017
Dosing time-dependent effect of raloxifene on plasma fibrinogen concentration in ovariectomized rats.
    Chronobiology international, 2008, Volume: 25, Issue:5

    Topics: Animals; Body Weight; Calcium; Circadian Rhythm; Female; Fibrinogen; Light; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Time Factors

2008
Tamoxifen and raloxifene produce conditioned taste avoidance in female rats: a microstructural analysis of licking patterns.
    Life sciences, 2009, Feb-27, Volume: 84, Issue:9-10

    Topics: Animals; Behavior, Animal; Body Weight; Conditioning, Operant; Drinking; Female; Humans; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Long-Evans; Selective Estrogen Receptor Modulators; Tamoxifen; Taste

2009
Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    European journal of pharmacology, 2009, Jul-01, Volume: 614, Issue:1-3

    Topics: Animals; Blood Pressure; Body Weight; Endothelin-1; Female; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Monocrotaline; Organ Size; Ovariectomy; Pulmonary Artery; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Substrate Specificity; Time Factors; Ventricular Dysfunction, Right

2009
A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
    Acta biochimica Polonica, 2009, Volume: 56, Issue:2

    Topics: Animals; Body Weight; Bone and Bones; Bone Density; Bone Marrow Cells; Bone Resorption; Calcification, Physiologic; Calcium; Cell Count; Cells, Cultured; Disease Models, Animal; Drug Combinations; Estradiol; Estriol; Female; Gene Expression; Genistein; Humans; Mice; Mice, Inbred BALB C; Organ Size; Osteoblasts; Osteoclasts; Osteoporosis, Postmenopausal; Ovariectomy; Phytoestrogens; Raloxifene Hydrochloride; Rats; Rats, Wistar; RNA, Messenger; Selective Estrogen Receptor Modulators; Thymus Gland; Uterus

2009
Biomechanical and histological outcome of combined raloxifene-estrogen therapy on skeletal and reproductive tissues.
    European journal of pharmacology, 2010, Feb-10, Volume: 627, Issue:1-3

    Topics: Animals; Body Weight; Bone and Bones; Bone Density; Drug Therapy, Combination; Estrogens; Female; Femur; Fractures, Bone; Organ Specificity; Osteopetrosis; Raloxifene Hydrochloride; Rats; Rats, Wistar; Risk; Tibia; Uterus

2010
Effects of tamoxifen and raloxifene on body and uterine weights of rats in persistent estrus.
    Clinical and experimental obstetrics & gynecology, 2012, Volume: 39, Issue:3

    Topics: Animals; Anovulation; Body Weight; Disease Models, Animal; Female; Organ Size; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Tamoxifen; Uterus

2012
Raloxifene acts as an estrogen agonist on the rabbit growth plate.
    Endocrinology, 2003, Volume: 144, Issue:4

    Topics: Animals; Body Weight; Cell Division; Chondrocytes; Contraceptive Agents, Female; Estradiol; Estrogen Antagonists; Female; Growth Plate; Organ Size; Rabbits; Raloxifene Hydrochloride; Tibia; Uterus

2003
Effects of long-term administration of N-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice.
    Journal of cellular biochemistry, 2003, Oct-01, Volume: 90, Issue:2

    Topics: Adipose Tissue; Animals; Body Weight; Bone Marrow Cells; Cholesterol; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Female; Fish Oils; Hypolipidemic Agents; Interleukin-1; Interleukin-10; Interleukin-6; Mice; Mice, Inbred BALB C; Ovariectomy; Ovary; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Skin; Spleen; Thiophenes; Triglycerides; Tumor Necrosis Factor-alpha

2003
Effects of SP500263, a novel selective estrogen receptor modulator, on bone, uterus, and serum cholesterol in the ovariectomized rat.
    Calcified tissue international, 2003, Volume: 72, Issue:6

    Topics: Administration, Oral; Animals; Body Weight; Bone Density; Bone Resorption; Cholesterol; Coumarins; Dose-Response Relationship, Drug; Female; Femur; Organ Size; Ovariectomy; Piperidines; Radiography; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Triglycerides; Uterus

2003
Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats.
    Endocrinology, 2004, Volume: 145, Issue:7

    Topics: Adaptation, Physiological; Adipose Tissue; Animals; Body Weight; Cholesterol; Estradiol; Estrogen Antagonists; Female; Hypothalamus; Leptin; Menopause; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Leptin

2004
Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:5

    Topics: Adenosine Triphosphate; Animals; Blood Platelets; Body Weight; Coronary Vessels; Estradiol; Estrogens, Conjugated (USP); Female; Gene Expression; Growth Substances; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Platelet Aggregation; Platelet Count; Raloxifene Hydrochloride; Receptors, Estrogen; RNA, Messenger; Selective Estrogen Receptor Modulators; Sus scrofa

2005
Restoration of endothelial function via enhanced nitric oxide synthesis after long-term treatment of raloxifene in adult hypertensive rats.
    Arzneimittel-Forschung, 2005, Volume: 55, Issue:2

    Topics: Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Bradykinin; Endothelium, Vascular; Female; Heart Rate; Hypertension; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Inbred SHR; Selective Estrogen Receptor Modulators; Superoxides

2005
A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2005, Volume: 20, Issue:12

    Topics: Absorptiometry, Photon; Amino Acids; Animals; Benzopyrans; Biomechanical Phenomena; Blood; Body Composition; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Cholesterol; Compressive Strength; Estrogen Receptor Modulators; Ethinyl Estradiol; Female; Femur; Femur Neck; Lumbar Vertebrae; Organ Size; Osteoclasts; Osteogenesis; Ovariectomy; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Tibia; Tomography, X-Ray Computed; Triglycerides; Uterus; Weight-Bearing

2005
Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthase in porcine aortic endothelial cells.
    Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:4

    Topics: Animals; Blotting, Western; Body Weight; Endothelial Cells; Estradiol; Estrogens, Conjugated (USP); Female; Horses; Ligands; Nitric Oxide; Nitric Oxide Synthase Type III; Ovariectomy; Phosphorylation; Raloxifene Hydrochloride; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Estrogen Receptor Modulators; Swine

2006
The effects of the selective estrogen receptor modulators, methyl-piperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus.
    Molecular reproduction and development, 2006, Volume: 73, Issue:8

    Topics: Animals; Apoptosis; Body Weight; Cell Line, Tumor; Endometrial Neoplasms; Endometrium; Estrogen Receptor alpha; Estrogen Receptor beta; Female; In Situ Nick-End Labeling; Mice; Mice, Knockout; Organ Size; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sheep; Uterus

2006
Comparative effects of estradiol, raloxifene, and genistein on the uterus of ovariectomized mice.
    Fertility and sterility, 2006, Volume: 86, Issue:4

    Topics: Animals; Body Weight; Estradiol; Female; Genistein; Mice; Mice, Inbred C57BL; Ovariectomy; Raloxifene Hydrochloride; Uterus

2006
The effects of raloxifene on tibia histomorphometry in ovariectomized rats.
    Endocrinology, 1994, Volume: 134, Issue:5

    Topics: Aging; Animals; Body Weight; Bone and Bones; Bone Development; Bone Resorption; Cell Count; Cholesterol; Female; Organ Size; Osteoclasts; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tibia; Uterus

1994
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
    The Journal of clinical investigation, 1994, Volume: 93, Issue:1

    Topics: Administration, Oral; Alkaline Phosphatase; Animals; Body Weight; Bone Density; Bone Resorption; Calcium; Cholesterol; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Estrogen Antagonists; Ethinyl Estradiol; Female; Hypertrophy; Ovariectomy; Phosphorus; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Triglycerides; Uterus

1994
Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate.
    Bone, 1996, Volume: 18, Issue:6

    Topics: Alendronate; Amino Acids; Animals; Biomarkers; Body Weight; Bone Resorption; Cholesterol; Disease Models, Animal; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Humans; Organ Size; Osteoporosis, Postmenopausal; Ovariectomy; Piperidines; Radioimmunoassay; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus

1996
Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:1

    Topics: Alendronate; Animals; Body Weight; Bone and Bones; Estrogens; Female; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Uterus

1996
LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:1

    Topics: Animals; Biomechanical Phenomena; Body Weight; Bone and Bones; Cholesterol; Estrogen Antagonists; Female; Organ Size; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Thiophenes; Uterus

1998
Adenomyosis--a result of disordered stromal differentiation.
    The American journal of pathology, 2001, Volume: 159, Issue:2

    Topics: Administration, Oral; Aging; Animals; Animals, Newborn; Body Weight; Calcium-Binding Proteins; Cell Differentiation; Endometriosis; Estradiol; Female; Gene Expression Regulation; Growth Inhibitors; Insulin-Like Growth Factor II; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Myometrium; Nerve Growth Factor; Oligonucleotide Array Sequence Analysis; Organ Size; Raloxifene Hydrochloride; Repressor Proteins; Selective Estrogen Receptor Modulators; Stromal Cells; Tamoxifen; Toremifene; Uterus

2001
Preventive effects of raloxifene and melatonin in N-methyl-N-nitrosourea-induced mammary carcinogenesis in female rats.
    Neoplasma, 2001, Volume: 48, Issue:4

    Topics: Animals; Anticarcinogenic Agents; Body Weight; Drinking; Eating; Female; Kinetics; Mammary Neoplasms, Experimental; Melatonin; Methylnitrosourea; Organ Size; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Uterus

2001
Selective estrogen receptor modulator effects in the rat brain.
    Neuroendocrinology, 2002, Volume: 75, Issue:1

    Topics: Amygdala; Animals; Body Weight; Brain; Carrier Proteins; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression; Hypothalamus; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Nerve Tissue Proteins; Ovariectomy; Pyrrolidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tamoxifen

2002
Effects of antiestrogens on adult and neonatal mouse reproductive organs.
    Reproductive toxicology (Elmsford, N.Y.), 1992, Volume: 6, Issue:5

    Topics: Animals; Animals, Newborn; Body Weight; Clomiphene; Estrogen Antagonists; Female; Genitalia, Female; Genitalia, Male; Male; Mice; Mice, Inbred C57BL; Nafoxidine; Organ Size; Ovariectomy; Ovary; Piperidines; Raloxifene Hydrochloride; Tamoxifen; Trifluoperazine; Uterus; Vagina

1992
Effects of anti-estrogens on bone in castrated and intact female rats.
    Breast cancer research and treatment, 1987, Volume: 10, Issue:1

    Topics: Animals; Body Weight; Bone and Bones; Estradiol; Estrogen Antagonists; Female; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Inbred Strains; Tamoxifen

1987